ARCT

Arcturus Therapeutics Holdings Inc.

27.34 USD
-0.11 (-0.40%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Arcturus Therapeutics Holdings Inc. stock is down -10.1% since 30 days ago. The next earnings date is Aug 5, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 58.33% of the previous 11 June’s closed higher than May. In the last 10 Unusual Options Trades, there were 8 CALLs, 2 PUTs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
28 May 15:23 19 Jul, 2024 30.00 CALL 110 15
28 May 16:35 20 Sep, 2024 30.00 CALL 63 327
28 May 19:37 20 Dec, 2024 40.00 PUT 50 0
05 Jun 14:32 20 Sep, 2024 35.00 CALL 34 393
05 Jun 14:32 20 Sep, 2024 35.00 CALL 52 393
05 Jun 14:36 20 Sep, 2024 35.00 CALL 56 393
11 Jun 17:54 21 Jun, 2024 40.00 PUT 50 156
11 Jun 18:08 20 Dec, 2024 35.00 CALL 177 27
12 Jun 18:11 20 Dec, 2024 35.00 CALL 126 205
12 Jun 18:11 20 Dec, 2024 35.00 CALL 74 205

About Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNar-CF program for cystic fibrosis lung disease. It has collaboration partnerships with Vinbiocare Biotechnology Joint Stock Company for the manufacture of COVID-19 vaccines.